Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Charles Holewinski who wrote (928)	3/3/1998 1:08:00 AM
From: John Zwiener	Read Replies (1) of 1115

Charles, you say........ <<>> Charles, that is exactly the point. (But the loan is up to 80- 130 million). Although we have made a wild, but educated guess that Lidakol will be the best drug for herpes with a 2 day improvement over the next best drug, how can an unknown company promise to loan that much money with one product (now under NDA). (There are other drugs further off, but who knows what they will do at this point). Healthmed is not really risking their money if they are able to get control of Lidak. Since they would want control in exchange for the loan, they can decide not to go through with spending the money. They can give the money back to Healthmed (for a fee of course IMO). Speculation is that Healthmed wants to control a potential giant drug with very little risk. I have to say it looks that way to me also. It seems on the surface that Lidak's board is trying to get more of a committment from Healthmed and to preserve an independent board. I read this as not allowing Healthmed to vote in and out board members at their whim.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next